Pharmacovigilance and Pharmacogenetics Flashcards
What is pharmacovigilance?
The identification, assessment and subsequent prevention of adverse drug reactions, whilst optimising the benefits of the drug
Who’s responsibility is it to report and identify ADR’s for pharmacovigilance?
- Prescribers
- Clinicians
- Patients
- Carers
- Pharmaceutical companies
- MHRA
How many cases of an ADR would need to be reported before anything was done about it today?
10 cases internationally
What ADR’s are classed as serious?
- Fatality
- Life threatening
- Prolonged hospitalisation
- Long term disability
- Congenital abnormalities
What are adverse drug reactions?
Unintended and noxious reactions that attributable to the therapeutic actions when given within normal therapeutic range
(any drug outside of TW can cause ADR)
What are the differences between Type A (augmented) and Type B (bizzare) adverse drug reactions?
What are some other classifications of ADRs that have been proposed?
- Chronic
- Delayed
- End of use
What is the ADR associated with the drug Diethylstilboestrol? (drug used to prevent premature labour)
An increase in vaginal cancer in those exposed to the drug in utero
What are the 4 broad mechanisms of action for ADRs?
- Exaggerated response of drug
- Desired pharmacological effect at an alternative/ additional site e.g. GTN spray for headache
- Additional/ secondary pharmacological effect
- Triggering an immunological response (anaphylaxis)
What are the limitations of pre-marketing clinical studies for identifying ADRs?
- Small number of patients
- Limited by age and/ or gender (typically male volunteers)
- Selected participants for precise diagnosis i.e. clinical trials use ‘ideal patients’ not always representative of the entire population
- Short, well defined duration of study
- Specialist doctors and continuous follow up
- Co-comitant therapeutics usually excluded
Why is relative risk of and ADR not always a good indicator of how common ADR’s are?
Depends on the baseline risk
A smaller relative risk in a population that has a high baseline risk gives more added cases!
What scheme is in place to report ADRs?
Yellow card reporting scheme
Used in both recently introduced (all suspected ADRs even minor ones reported) and well established products (serious and unexpected)
What is the black triangle on drug products?
Warning on new drugs or newly repurposed drugs that prompts extra vigillence when prescribing
What are the advantages and disadvantages of the yellow card reporting scheme?
Advantages:
- Simplicity
- Timely and theoretically inexpensive
- Detects both common and rare reactions
- Accessible by all HCPs, patients and carers
Disadvantages:
- inevitable under reporting
- Positive bias to serious reactions/ new drugs
- Duplication
- Incomplete poor quality data
What is pharmacogenetics?
How an individual gene may affect the response to a drug or the drugs effect on the body